{
    "clinical_study": {
        "@rank": "102545", 
        "arm_group": {
            "arm_group_label": "ACLF and Acute Liver Failure (ALF)..", 
            "arm_group_type": "No Intervention", 
            "description": "Methacetin Breath Test will be done on Day 0,7,14,28 in Acute on Chronic Liver Failure (ACLF)and  on day 0,1,3,7 in Acute Liver failure (ALF)."
        }, 
        "brief_summary": {
            "textblock": "Blood will be collected after venepuncture from all patients for complete blood counts,\n      Serum bilirubin (direct and indirect), aspartate aminotransferase, alanine aminotransferase,\n      alkaline phosphatase, gamma glutamyl transferase, prothrombin time and INR, urea,\n      creatinine, sodium, potassium, serum total protein and albumin, within 24 hours after\n      admission and twice a week there after or as and when needed.\n\n      Time line for blood tests and evaluation of clinical parameters & 13C-MBT\n\n      For ALF patients:\n\n      On days 0, 1, 3, and 7\n\n      For ACLF patients:\n\n      On days 0, 7 (week 1), 14(week 2), 28 (weeks 4)\n\n      Blood tests would include:\n\n      Serum bilirubin (total and direct), aspartate aminotransferase, alanine aminotransferase,\n      alkaline phosphatase, gamma-glutamyltransferase, Serum proteins (total and albumin),\n      prothrombin time & international normalized ratio (INR),  Serum urea and creatinine, serum\n      electrolytes, arterial ammonia and arterial blood gas analysis."
        }, 
        "brief_title": "Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Liver Failure", 
            "Acute on Chronic Liver Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Liver Failure", 
                "Liver Failure, Acute", 
                "End Stage Liver Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - All patients presenting with acute liver failure and acute on chronic liver failure\n        (between 18 - 70 years of age) to Institute of Liver & Biliary Sciences (ILBS), New Delhi,\n        India.\n\n        Exclusion Criteria:\n\n          1. Patients with significant co-morbid illnesses such as cardiovascular or respiratory\n             or intrinsic renal diseases which by themselves may have a bearing on the outcome.\n\n          2. Patients with previous intestinal bypass surgery for morbid obesity\n\n          3. Patients with extensive small bowel resection\n\n          4. Patients currently receiving total parenteral nutrition\n\n          5. Pregnant women\n\n          6. Patients with history of allergy to paracetamol\n\n          7. Patients on steroids or anti-fungal agents\n\n          8. Patients in encephalopathy\n\n          9. Patients unwilling to participate in the protocol\n\n         10. Patients on medications which can alter the activity of CYP 1A2 enzymes such as\n             corticosteroids, amiodarone, tetracycline, niacin, valproic acid, methotrexate,\n             stavudine and zidovudine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "256", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946360", 
            "org_study_id": "ACLF-MBT"
        }, 
        "intervention": {
            "arm_group_label": "ACLF and Acute Liver Failure (ALF)..", 
            "description": "Methacetin Breath Test will be done on Day 0,7,14,28 in Acute on Chronic Liver Failure (ACLF)and on day 0,1,3,7 in Acute Liver failure (ALF).", 
            "intervention_name": "Methacetin Breath Test in ACLF and ALF patients", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New Delhi", 
                    "country": "India", 
                    "state": "Delhi", 
                    "zip": "110070"
                }, 
                "name": "Institute of Liver & Biliary Sciences"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "chitranshuv@hotmail.com", 
            "last_name": "Dr Chitranshu Vashishtha, DM", 
            "phone": "011-46300000", 
            "phone_ext": "1042"
        }, 
        "overall_contact_backup": {
            "email": "bhardwaj.ankit3@gmail.com", 
            "last_name": "Dr Ankit Bhardwaj", 
            "phone": "011-46300000", 
            "phone_ext": "1032"
        }, 
        "overall_official": {
            "affiliation": "Institute of Liver & Biliary Sciences.", 
            "last_name": "Dr Shiv Kumar Sarin, DM", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Survival or Transplantation for Acute Liver Failure (ALF).", 
            "safety_issue": "Yes", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946360"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Mortality or Transplantation for Acute on Chronic Liver Failure (ACLF) patients.", 
            "safety_issue": "Yes", 
            "time_frame": "12 weeks"
        }, 
        "source": "Institute of Liver and Biliary Sciences, India", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institute of Liver and Biliary Sciences, India", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}